Clinical Trials in Philadelphia

Showing 12901-12920 of 17,926 trials

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

NCT00726323

This clinical study is being conducted at multiple sites to determine the best confirmed response rate, safety, and tolerability of GSK1363089 treatment in papillary renal cell carcinoma. Papillary renal cell carcinoma may be classified into hereditary and sporadic forms; subjects with either classification will be accepted into this study.

Carcinoma, Renal Cell

GlaxoSmithKline74 participantsStarted Jun 2006

Greenbrae, California, United States • San Francisco, California, United States • Stanford, California, United States +9 more locations

COMPLETEDPhase 2< 1 mile

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT00486200

A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.

Herpes Genitalis

Astellas Pharma Inc695 participantsStarted Jun 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +22 more locations

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Find Trials by Condition in Philadelphia

A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk

Use of Infliximab for the Treatment of Pemphigus Vulgaris

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Safety and Efficacy Trial of Testosterone Undecanoate

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease

A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Comparison of Cervical Laminectomy to Laminoplasty

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers